Ban Against Insulin Pump Patch Sales Reversed by Fed. Cir. (1)

The Federal Circuit reversed a lower court’s injunction against EOFlow Co. Ltd.'s sale of insulin pump patches using Insulet Corp. trade secrets, finding a litany of deficiencies in the ban.

A preliminary injunction issued Monday against the medical device maker failed to properly establish a likelihood of success or irreparable harm, the US Court of Appeals for the Federal Circuit said. A Massachusetts federal court failed to address a statute of limitations or adequately define the trade secrets, Circuit Judge Alan David Lourie said.

The opinion comes months after medical device giant Medtronic PLC canceled their agreement to acquire EOFlow, ...